Concepedia

Author

Megan Halbrook

University of California, Los AngelesORCID

Also Known As

Halbrook, Megan, M Halbrook, Megan Halbrook, Rimoin, Anne W, Rimoin, Anne W.

49

Publications

501

Citations

10

H-Index

36

Concepts

All Affiliations

University of California, Los AngelesNational Institute of Biomedical ResearchMinistry of Public HealthStanford UniversityUniversity of California, San Francisco
MH

About

Megan Halbrook is an author at University of California, Los Angeles specializing in medicine, epidemiology, and vaccine safety.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

331

2

Epidemiology

4

4

316

3

Public Health

2

2

291

4

Community Health Sciences

1

1

205

5

Health Policy

1

1

86

Megan Halbrook

×

10

Publications

431

Citations

10

H-Index

YearCitations

Cross-sectional Assessment of COVID-19 Vaccine Acceptance Among Health Care Workers in Los Angeles

Adva Gadoth, Megan Halbrook, Rachel Martin‐Blais,

Annals of Internal Medicine

2021

205

Assessment of COVID-19 vaccine acceptance among healthcare workers in Los Angeles

Adva Gadoth, Megan Halbrook, Rachel Martin‐Blais,

2020

86

Longitudinal Assessment of Coronavirus Disease 2019 Vaccine Acceptance and Uptake Among Frontline Medical Workers in Los Angeles, California

Megan Halbrook, Adva Gadoth, Rachel Martin‐Blais,

Clinical Infectious Diseases

2021

42

Humoral responses to SARS-CoV-2 mRNA vaccines: Role of past infection

Ashley Gray, Rachel Martin‐Blais, Nicole H. Tobin,

PLoS ONE

2021

19

Notes from the Field: Fungal Bloodstream Infections Associated with a Compounded Intravenous Medication at an Outpatient Oncology Clinic — New York City, 2016

Amber Vasquez, Jason Lake, Stephanie Ngai,

MMWR Morbidity and Mortality Weekly Report

2016

15

Sex Difference in Meningococcal Disease Mortality, New York City, 2008–2016

Danielle Bloch, Kenya Murray, Eric Peterson,

Clinical Infectious Diseases

2018

14

Epidemiology and phylogenomic characterisation of two distinct mpox outbreaks in Kinshasa, DR Congo, involving a new subclade Ia lineage: a retrospective, observational study

Tony Wawina-Bokalanga, Sydney Merritt, Eddy Kinganda-Lusamaki,

The Lancet

2025

14

Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccination in exposed and potentially exposed persons in the Democratic Republic of the Congo

Nicole A. Hoff, Anna Bratcher, J. Daniel Kelly,

Proceedings of the National Academy of Sciences

2022

13

Human T-cell lymphotropic virus type 1 transmission dynamics in rural villages in the Democratic Republic of the Congo with high nonhuman primate exposure

Megan Halbrook, Adva Gadoth, Anupama Shankar,

PLoS neglected tropical diseases

2021

12

Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo

Anna Bratcher, Nicole A. Hoff, Reena H. Doshi,

PLoS neglected tropical diseases

2021

11

Page 1